KB105 ( DrugBank: - )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
160先天性魚鱗癬1

160. 先天性魚鱗癬


臨床試験数 : 36 薬物数 : 72 - (DrugBank : 21) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 111
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04047732
(ClinicalTrials.gov)
August 27, 201929/7/2019Topical KB105 Gene Therapy for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)A Phase I/II Clinical Trial of Topical KB105, a Replication-incompetent, Non-integrating HSV-1 Vector Expressing Human Transglutaminase 1 (TGM1) for the Treatment of TGM1-deficient Autosomal Recessive Congenital Ichthyosis (ARCI)TGM-1 Related Autosomal Recessive Congenital IchthyosisBiological: KB105Krystal Biotech, Inc.NULLActive, not recruiting18 YearsN/AAll6Phase 1/Phase 2United States